By analyzing cell shape, viability, uptake, apoptotic cell death, the cell cycle, and caspase-3 gene expression levels, the effects of the combined therapy were evaluated, and insights into the molecular interactions of these active chemicals with HCT116 cancer cells were obtained. This evidence concerns the gene CASP3 and cancer.